A study presented at the 2010 annual fall meeting of the American Society of Regional Anesthesia and Pain Medicine looked at eight patients who received injections of Botox-A in three trigger points. According to the report, the patients experienced pain relief for only eight weeks before pain returned.
Researchers said the results line up with prior research, though the small sample size (eight patients) limits the findings’ significance.
Read the full Anesthesiology News report on Botox-A (login required).
Read more on anesthesia:
–Mass General Anesthesiologists to Provide Coverage at Martha’s Vineyard Hospital
–Montana Anesthesiologist Gets Three Years Probation for Prescription Fraud
–Anesthesiologist on the Move: Dr. Michael Semenovski Joins BAETA as CMO
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.